Celluvisc

Quick links to important sections

Celluvisc

Method of action: Ophthalmologicals

Treatment option:

Medically reviewed

Rosario Oropesa

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Celluvisc

Quick Facts

Property Description
Active ingredient Carmellose Sodium
Form Ophthalmic Solution (Eye Drops)
Pharmacological class Ocular Lubricant / Artificial Tears
Common use Relief of dryness and irritation
Origin Synthetic Polymer (Cellulose Derivative)

Core Identity: What Type of Medicine is Celluvisc?

Celluvisc is an ophthalmic solution whose active ingredient, Carmellose Sodium, places it in the pharmacological class of Ocular Lubricants, commonly known as Artificial Tears. This medication is specifically designed for ocular (topical eye surface) application, providing non-medicated, physical relief by supplementing the eye’s natural moisture layer. The product is often provided in single-dose units, which makes the formulation preservative-free. This is a distinctive feature, particularly for patients who require frequent application or those who are sensitive to the preservatives found in many multi-dose eye preparations.


Carmellose Sodium: Composition and Origin

The formulation is centered on Carmellose Sodium, which is chemically known as Carboxymethylcellulose Sodium, the official INN (International Nonproprietary Name). This compound is a synthetic polymer that is derived from natural cellulose, a substance found in fibrous plant material. Its composition is designed to be highly compatible with the eye.

This medication is presented as a single-ingredient product, containing only Carmellose Sodium suspended in a sterile Aqueous Vehicle (a water-based solution). The synthetic yet biocompatible nature of the polymer allows it to function as a demulcent that adheres to the ocular surface, providing a protective coating and supporting the physical integrity of the external ocular tissues.


What is the General Purpose of Celluvisc?

The general purpose of Celluvisc is to provide sustained moisture supplementation and ocular surface protection through its physical properties. It works as a Viscosity Enhancer to stabilize the natural tear film and slow down the rate of moisture loss from the eye's surface. A typical scenario for its use is providing comfort during long periods of screen work or when exposed to dry environments.

The use of lubricating eye drops is a recognized strategy for managing surface discomfort. This class of medicine helps provide symptomatic relief from sensations of dryness, burning, and general discomfort by physically supporting the eye's protective film.

Regulatory References

  1. NIH DailyMed: Carboxymethylcellulose Sodium Ophthalmic Solution

What side effects are possible with Celluvisc?

Possible Side Effects and Safety Information

This section outlines the officially documented adverse effects and safety characteristics of Celluvisc (Carmellose Sodium Ophthalmic Solution), based strictly on government regulatory documents.


Official Adverse Reactions and Frequency

The most commonly reported effects are localized to the eye. Adverse reactions are classified by frequency according to regulatory standards (e.g., EMA/ICH).

Frequency Classification System Organ Class (SOC) Adverse Reaction (AR) Examples
Common (ge 1/100 to < 1/10) Eye Disorders Eye irritation (including burning and discomfort), Eye pain, Eye pruritus (itching), Visual disturbance
Uncommon (ge 1/1,000 to < 1/100) Immune System Disorders Hypersensitivity (including eye allergy)
Uncommon (ge 1/1,000 to < 1/100) Eye Disorders Blurred vision, Lacrimation increased, Ocular hyperemia (redness), Foreign body sensation

Serious adverse events are rare but include Hypersensitivity reactions and Superficial injury of the eye, often associated with improper administration technique.


Safety Considerations and Constraints

Contraindication: The only absolute contraindication is known hypersensitivity to the active substance, Carmellose Sodium, or any of the inactive ingredients.

Visual Safety: Because the solution can cause transient blurring of vision, regulatory guidelines note a potential minor impact on the ability to drive or operate machinery immediately after use.

Population Status: The safety and efficacy of this medicine have not been established in the pediatric population. Due to the minimal to negligible systemic absorption of Carmellose Sodium, its use is considered permissible during pregnancy and breast-feeding by many regulatory bodies.

Worsening Symptoms: Official warnings advise that if eye pain, redness, or irritation worsen or persist for more than 72 hours, use should be stopped and a healthcare professional consulted.

Overdose and Emergency Response

Overdose and when to Seek Help

The regulatory guidance on overdose for Celluvisc (Carmellose Sodium) is based on its minimal potential for systemic absorption as an ocular lubricant. The risk of severe systemic toxicity following an overdose is considered low, as the compound is minimally absorbed from both the ocular surface and the gastrointestinal tract.


Officially Documented Manifestations and Required Actions

Category Regulatory Documentation Status
Anticipated Manifestations Increased ocular irritation and temporary change in visual acuity (localized to the eye).
Systemic Risk Severe systemic toxicity is not anticipated due to low bioavailability.
Antidote Status No specific antidote is known or documented.
Management Restricted to symptomatic and supportive treatment.

When to Seek Urgent Medical Help

For an overdose limited to the eye (excess topical application), the official regulatory instruction is to rinse the eye with water to remove the product.

The mandate to seek urgent medical intervention is specifically triggered by accidental oral ingestion. Individuals are required to seek immediate medical attention or contact a Poison Control Center if the product is swallowed. This action is necessary for guidance, even though severe effects are not generally expected by regulatory authorities.

Therapeutic Uses of Celluvisc

Quick Facts on Celluvisc Uses

  • Relief Target: Provides temporary support for relief of discomfort related to eye dryness.
  • Symptoms Addressed: Works to help address burning, irritation, and dryness symptoms.
  • Protective Use: May offer support as a protectant against further surface irritation.

Celluvisc is primarily used to support the management of symptoms associated with dry eye conditions. Its formulation is intended to help restore moisture to the ocular surface, acting as a tear substitute. This action may offer support for the temporary relief of common symptoms such as a burning sensation, irritation, and general discomfort that often accompany dryness of the eye.

The use of this solution can help address dryness resulting from insufficient tear production, as well as symptoms triggered by exposure to wind, sun, or prolonged visual effort. The product may be used to protect the eye's surface from further drying or irritation by creating a lubricating layer.

Regulatory References

  1. NIH MedlinePlus guidance

Eligibility and Restrictions for Use

Eligibility Scope

Classification Rule (Official Regulatory Wording)
Populations for whom use is allowed Adults are permitted to use the medicine under standard labeled conditions.
Populations for whom use is contraindicated Hypersensitivity to the active substance carmellose sodium or to any of the excipients in the formulation.
Pregnancy and lactation eligibility status Use is permitted during pregnancy and breast-feeding due to the negligible systemic exposure.
Condition-specific eligibility rules No specific restrictions are documented for patients with renal or hepatic impairment.

Age-Related Eligibility Rules

  • Adults and Older Adults: Use is established.
  • Children and Adolescents (Paediatric Population): For the 0.5% strength, safety and efficacy are supported by clinical experience. However, the regulatory status for the 1.0% strength is not established due to a lack of available clinical trial data.

Connection to the Overall Eligibility Profile

Official regulatory documents define the user population primarily by a single strict exclusion: hypersensitivity to the drug's components. For the general adult population, use is allowed. Eligibility is extended to pregnant and breastfeeding individuals. The only area of conditional eligibility relates to pediatric use, reflecting the status of clinical trial data for specific product strengths.

What should I know about interactions with other medicines?

Celluvisc (carboxymethylcellulose sodium) is primarily an ocular lubricant used for dry eyes. Due to its mechanism of action as a tear substitute and its negligible systemic absorption, it is not generally associated with significant drug-to-drug interactions with oral medications.

Concurrent Use of Other Eye Medications

When using Celluvisc with other ophthalmic products, the main concern is that Celluvisc's high viscosity could dilute or interfere with the absorption of the second medicine. To prevent this, a specific minimum interval must be maintained between applications. This is a critical factor for ensuring the efficacy of any concurrent eye drops or ointments.

  • Eye Drops: If you are using another type of eye drop, wait at least 15 minutes before applying Celluvisc. This allows the first medication to be fully absorbed.
  • Eye Ointments: If you are using an eye ointment, the general recommendation is to apply the drops (Celluvisc or other solutions) before the ointment. A separation of at least 15 minutes between the application of any two products is advised.

Always inform your doctor or pharmacist about all prescription, over-the-counter (OTC) eye drops, or any other ocular products you are using. They may need to adjust the timing of your treatments.

Mechanism of Action

Carboxymethylcellulose (CMC), a high molecular weight anionic polymer, is instilled onto the ocular surface. The substance exhibits mucoadhesive properties, facilitating its binding to the carbohydrate moieties present in the mucin layer of the corneal and conjunctival epithelial cells. This specific interaction is driven by intermolecular forces and results in the retention of the polymer on the ocular surface. The hydrogel nature of CMC immediately promotes the formation of a localized, viscoelastic polymer layer, which serves as an additional stratum over the existing tear film structure. The high intrinsic viscosity of the CMC formulation directly modulates the biophysical dynamics of the tear film. Specifically, the increased viscous barrier mechanically decreases the rate of aqueous phase evaporation from the tear film surface, thus sustaining the volume of the tear layer. This mechanism constitutes a physiological modulation of the ocular surface environment, driven purely by the physical and chemical properties of the polymer.

Dosage and Administration Information

Administration Process

Celluvisc is typically provided in single-dose containers. The preparation involves twisting the top off the unit to open it. When applying the drops, the head is tilted back and the lower eyelid is gently pulled down to create a small pocket. The container is held over the eye, and the prescribed number of drops is released into the conjunctival sac. To avoid contamination, the tip of the container should not touch the eye, eyelids, or any other surface.

After Application

Once the drop has been administered, the eye should be closed for a short period. Applying light pressure to the inner corner of the eye (near the nose) for approximately one minute can help keep the liquid on the surface of the eye. If the product is being used alongside other ophthalmic medications, a specific interval of time is usually maintained between the applications of different products to ensure proper absorption.

Handling and Storage

Single-use containers are designed for immediate use after opening. Because these units do not contain preservatives, any remaining solution in the container is discarded after the initial application. Using a fresh container for each administration helps maintain the sterility of the solution and supports ocular hygiene.

Recent Clinical Evidence

Research Evidence / Overview of Studies for Celluvisc

Evidence for Use in General Dry Eye Symptoms

The research evidence for Carmellose Sodium (Celluvisc) has primarily been developed through well-designed Randomized Controlled Trials (RCTs). These studies were used in research exploring the symptoms of dry eye disease, comparing Carmellose Sodium formulations against a placebo or against other commercially available eye lubricants. Researchers monitored whether participants reported changes in patient-reported outcomes describing perceived discomfort, such as burning and irritation. They also monitored objective outcomes related to functional imbalance, such as the stability of the natural tear film and the health of the eye's surface.

Evaluation in Specific Clinical Contexts

In addition to general studies, Carmellose Sodium was evaluated in specific clinical contexts. This research explored short-term symptom changes in adult patients who had recently undergone cataract surgery (phacoemulsification). Studies monitored the need for further dry eye intervention and tracked ocular surface signs during the initial post-operative recovery period.

Study Design: Outcomes and Comparators Examined

The research examined whether the use of the product was studied for changes in patient-reported outcomes when compared to a placebo (an inactive substance). Research has also explored Carmellose Sodium in studies compared against other types of ocular lubricants. However, comparative evidence is often complicated because many trials evaluated multi-ingredient formulations that contained Carmellose Sodium alongside other components.

Long-Term Evidence and Follow-up Duration

Most high-quality clinical trials observed responses over defined time intervals that were relatively short, often up to three months (90 days). Long-term effects are not fully established, and there is limited information regarding the maintenance of symptom patterns beyond these initial study periods.

Key Uncertainties and Research Gaps

Evidence suggests that results apply mainly to the populations studied (adults with mild-to-moderate disease). Data for certain groups, such as pediatric patients or those with very severe cases of dry eye disease, remain insufficient. These factors contribute to the ongoing evidence landscape where additional research is always being monitored.

Key Studies & References Carboxymethylcellulose Sodium Ophthalmic Solution, USP (Celluvisc) - NIH DailyMed Label

Frequently Asked Questions (FAQ)

Common questions about Celluvisc (FAQ)


Q: How long does the moisturizing relief from Celluvisc typically last?

Celluvisc's active ingredient, carmellose sodium, is formulated with a high viscosity (thickness). Official information indicates this design helps increase the product's retention time on the surface of the eye. This extended retention is designed to support prolonged lubrication for the relief of dry eye symptoms.


Q: Is it normal to experience temporary blurred vision right after using Celluvisc?

Official regulatory guidelines state that Celluvisc may cause transient, or temporary, blurring of vision. This effect is expected due to the product’s high viscosity as it settles on the eye's surface. Warnings note that this visual disturbance may briefly impact your ability to drive or operate machinery immediately after using the drops.


Q: Does Celluvisc cause a stinging or burning sensation when first applied?

Eye irritation, which includes a burning or discomfort sensation, is listed as a common adverse reaction in the official product information. Official warnings state that if discomfort worsens or persists for more than 72 hours, product use should be discontinued and a healthcare professional should be consulted.


Q: What are the inactive ingredients in Celluvisc and what role do they play?

The inactive ingredients, or excipients, in Celluvisc are generally water-based and include several electrolytes, such as calcium chloride, potassium chloride, sodium chloride, and sodium lactate. The purpose of these ingredients is to help balance the solution's properties, such as its pH, to make it compatible with the eye's natural tears.


Q: Can the single-use vials of Celluvisc be closed and re-used later in the same day?

Official administration rules state that the single-dose container must be used immediately upon opening and discarded right away, even if solution remains. The product is preservative-free, and this rule must be followed to maintain sterility and prevent the risk of contamination.


Q: If I use another eye medication, how long should I wait before using Celluvisc?

Official administration guidelines state that if Celluvisc is used concurrently with any other topical eye medication, there must be an interval of at least 15 minutes between applications. This required interval is designed to help prevent the high viscosity of Celluvisc from interfering with the absorption or effectiveness of the first medicine.


Q: What should I do if my eyes feel worse or more irritated after using Celluvisc?

Official warnings state that product use should be stopped and a healthcare professional consulted if eye pain, changes in vision, persistent redness, or irritation worsens or lasts for more than 72 hours.


Q: Does Celluvisc have any known interactions with oral medications?

No interactions are expected with oral medications. Official documentation states that no interaction studies were performed because the active ingredient, carmellose sodium, is minimally absorbed into the body when applied to the eye.


Q: Is Celluvisc considered a regular artificial tear or something stronger?

Celluvisc is often described as a Lubricant Eye Gel or a high-viscosity solution, rather than a standard artificial tear liquid. This distinction is due to its high viscosity formulation, which is thicker and designed to offer sustained lubrication for dry eye symptoms.


Q: Why does Celluvisc have a thicker, gel-like consistency compared to other eye drops?

The thickness of Celluvisc comes from its active ingredient, carmellose sodium, which is formulated with a very high viscosity. This viscosity is designed to help the product remain on the ocular surface for a longer duration, supporting sustained lubrication.


Q: What is the difference between Celluvisc and other Refresh brand eye drops?

The product profile highlights its high viscosity and single-dose, preservative-free nature, which generally differentiates it as a thicker solution intended to provide sustained lubrication compared to standard, thinner formulations.


Q: Can Celluvisc be used for dry eyes caused by computer screen use?

Celluvisc is indicated for the temporary relief of burning, irritation, and discomfort due to eye dryness. These are symptoms that are often associated with extended periods of screen use.


Q: Is Celluvisc recommended for dry eyes specifically related to aging?

Celluvisc is indicated for the treatment of dry eye symptoms in the general adult population. Official labeling does not place any specific restrictions or primary labeling based on age-related dry eye, but it is a common treatment option for adults.


Q: Why might a person with severe dry eye symptoms choose Celluvisc?

Professional information suggests that the 1% concentration formulation of Celluvisc is often used for individuals experiencing moderate to severe dry eye symptoms. This is due to its high viscosity, which provides enhanced ocular surface lubrication.


Q: Can Celluvisc be used at night or for overnight moisture?

Celluvisc is generally administered on an as-needed basis and is often considered appropriate for day or night use. Its thicker, high-viscosity formulation is designed to support moisture retention and comfort, which some individuals may find useful during sleep.


Q: Is Celluvisc available over-the-counter or does it require a prescription?

According to the Drug Facts label in the United States, Celluvisc (carboxymethylcellulose sodium) is generally classified as an Over-The-Counter (OTC) Human Drug. This means it can typically be purchased without a doctor’s prescription.


Q: Can Celluvisc help with irritation or discomfort from wind and sun exposure?

Official uses state that Celluvisc is indicated for the temporary relief of irritation and discomfort caused by exposure to wind or sun. It can also act as a protectant against further environmental irritation.


Q: Is Celluvisc safe for people with very sensitive eyes or a history of allergies?

The product is preservative-free, a feature that may be preferred by individuals with sensitive eyes or those who require frequent use. However, its use is strictly contraindicated if there is a known allergy or hypersensitivity to the active ingredient, carmellose sodium, or any other components in the formula.


Q: Why do some people report residue or stickiness on their eyelashes after using Celluvisc?

The presence of residue, or eyelid margin crusting, is listed as an uncommon side effect in official documents. This is a potential physical result of using a thick, high-viscosity solution on the eye's surface.


Q: What is the difference between the 0.5% and 1% concentrations of Celluvisc (carmellose sodium)?

Celluvisc is available in different concentrations, most commonly 0.5% and 1.0% carmellose sodium. Official information indicates that the 1% concentration is often associated with the management of more severe or chronic dry eye symptoms.


Q: How quickly should I expect relief after instilling the drops?

The medicine is designed to work upon contact with the eye, where it immediately forms a protective layer. This action is intended to provide physical relief for the symptoms of dry eye.


Q: What is the significance of the electrolytes like potassium and calcium chloride in the formula?

The formula contains electrolytes such as potassium and calcium chloride, along with sodium chloride and sodium lactate. These ingredients are included to ensure the solution is isotonic and pH-balanced, helping it to be compatible and non-irritating to the eye.


Q: Is it necessary to remove contact lenses before using Celluvisc?

Official safety precautions state that contact lenses must be removed prior to applying the eye drops. Lenses can then be reinserted after an interval of at least 15 minutes.


Q: Is Celluvisc designed to treat inflammation associated with dry eyes?

Celluvisc is classified solely as an ocular lubricant, and it does not contain medicinal ingredients for inflammation. Its function is to treat the symptoms of dry eye, such as burning and irritation, by providing a physical protective barrier and moisture.


Q: Are there any known drug interactions that can reduce the effectiveness of Celluvisc?

Official documentation states that concurrent use with other eye products may lead to reduced effectiveness for either product. To prevent the second product from interfering with Celluvisc, an interval of at least 15 minutes between topical eye medications is required.


Q: If I accidentally swallow a small amount of Celluvisc, is it dangerous?

Official information indicates that accidental oral overdose is generally not expected to be hazardous. However, if swallowed, the guidance is to contact a Poison Control Center or seek immediate medical help.


Q: Is it better to use Celluvisc at certain times of the day?

Celluvisc is administered on an as-needed basis, also known as PRN, which means it should be used whenever required to manage your symptoms. There is no official mandatory time of day for administration; it is used solely based on when relief is needed.


Q: Do all versions of Celluvisc contain the same amount of active ingredient?

Official product information indicates that Celluvisc is available in different strengths of the active ingredient, carmellose sodium. The two main concentrations available are typically 0.5% w/v and 1.0% w/v.

How should Celluvisc be stored and disposed of?

How to Store and Dispose of Celluvisc?

Celluvisc (Carmellose Sodium) storage must strictly follow regulatory labeling to maintain product stability.

Storage Requirements

Store the ophthalmic solution at controlled room temperature, specifically between 59^circ to 77 F (15^circ to 25 C). It is mandatory to keep the product out of the sight and reach of children.

Do not freeze the solution. The single-dose containers must remain in their original foil pouch and outer carton until they are needed. Do not use the medicine if it has passed its expiration date or if the solution appears discolored or cloudy.

Disposal Instructions

Each opened single-dose container must be discarded immediately after use; do not store any remaining solution. Expired or unused medicine must not be disposed of in household waste or wastewater, and should be returned to a pharmacist or a designated collection point.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Celluvisc found in:

A-Z Index: